Crystalline chemotherapeutic

Details for Australian Patent Application No. 2008312532 (hide)

Owner Abbott Laboratories

Inventors Rozema, Michael J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008312532

PCT Pub. Number WO2009/052229

Priority 60/981,243 19.10.07 US

Filing date 16 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/052229 Priority application(s): WO2009/052229

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312533-Crystalline chemotherapeutic

2008312529-Crystalline indazole-derived chemotherepeutic